Kepivance Lyophilisate For Solution For Injection 6.25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Kepivance: Lyophilisate for solution for injection (6.25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PALIFERMIN (pal ee FER min) is a man-made form of a natural growth factor. It is used to treat and to prevent severe mouth sores in patients with blood-related cancers receiving chemotherapy and/or radiation therapy.

In-Depth Information
Select a Medication

Kepivance 6.25mg Powder for Injection

NDC: 666580112
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Stomatitis

Storage Information
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Store in original package until time of use
Protect from light
Reconstituted product may be stored refrigerated in its carton at 36 to 46 degrees F for up to 24 hours if not used immediately
Do not freeze
Discard unused portion. Do not store for later use.
Kepivance 6.25mg Powder for Injection

Reported Side Effects for Kepivance 6.25mg Powder for Injection

Antibody Formation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
High Blood Pressure Incidence:
7.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Dysesthesia Incidence:
12.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
16.0%*
Severity: MILD
Onset: EARLY
Tongue Discoloration Incidence:
17.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
28.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
32.0%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
35.0%*
Severity: MILD
Onset: RAPID
High Amylase Levels Incidence:
38.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
39.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Kepivance

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5